Case in point
Case in point
03/05/2025
Daniel Sweeney, MD; Sanja Zepcan, PharmD; Patrick Hagen, MD; Stephanie Tsai, MD
Angiotensin-converting enzyme inhibitors (ACEi) are a common class of medication used to treat hypertension as a first-line therapy. Common side effects of ACEi include dry cough, hyperkalemia, and renal...
03/05/2025
What's The Take Home?
What's The Take Home?
02/10/2025
Ronald N. Rubin, MD
A 44-year-old woman presents for evaluation with new fatigue and worsening shortness of breath with exertion. The patient noted that she has valvular heart disease related to an episode of rheumatic fever...
02/10/2025
What's The Take Home?
What's The Take Home?
01/17/2025

Ronald N. Rubin, MD1,2 Series Editor

Ronald N. Rubin, MD1,2 —Series E...
A 52-year-old woman has been experiencing sporadic panic attacks for several months that are not related to any specific behaviors or exposures. The attacks are characterized by a racing and strong pounding...
01/17/2025
Commentary
bloch
Commentary
01/01/2024
In this article, Michael J. Bloch, MD, writes about evidence against using a chronotropic strategy for blood pressure control and compares the results of various studies following strategies for blood...
01/01/2024
Commentary
Michael J Bloch, MD
Commentary
09/17/2023
In this article, Michael J. Bloch, MD, compares the use of chlorthalidone vs hydrochlorothiazide in the management of adults with high blood pressure, including the results of The Chlorthalidone vs...
09/17/2023
Photoclinic
Photoclinic
08/03/2022
An 8-year-old boy with a history of psoriasis presented to the pediatric emergency department for evaluation of 6 days of headache and fatigue.
08/03/2022
What's the Take Home?
What's the Take Home?
08/04/2021
A 62-year-old man presented to the emergency department after being referred by his internist when excessively elevated blood pressure readings were recorded. He had presented to his physician after having...
08/04/2021
What's the Take Home?
What's the Take Home?
03/02/2021
In this column, we will continue discussing the 62-year-old man from last month’s column. The patient had been adherent to the prescribed treatment regimen and was doing well following his episode of...
03/02/2021
Risk Management
Risk Management
11/16/2020
In part 2 of our “Test Your Knowledge” series, Michael Bloch, MD, asks you to identify which factor is most likely contributing to the patient’s resistant hypertension.
11/16/2020
Letters to the Editor
Letters to the Editor
04/06/2020
Franklin Lowe, MD, responds to a commentary written by Michael J. Bloch, MD, about the pharmacopeia of antihypertensives.
04/06/2020